VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 110 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $237,000 | +82.3% | 28,400 | +176.2% | 0.10% | +218.8% |
| Q2 2015 | $130,000 | -16.7% | 10,281 | -5.7% | 0.03% | -38.5% |
| Q4 2014 | $156,000 | -40.7% | 10,900 | -32.7% | 0.05% | -32.5% |
| Q1 2014 | $263,000 | +39.2% | 16,200 | +6.6% | 0.08% | +14.9% |
| Q4 2013 | $189,000 | -80.1% | 15,200 | -87.1% | 0.07% | -63.0% |
| Q2 2013 | $949,000 | – | 117,400 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |